Sun Pharma.Inds.

SUNPHARMACEUTICALSINDUSTRIES30 Apr 2024

Pharmaceuticals

₹

-19.50 (-1.28%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Sun Pharma.Inds.

Sun Pharma.Inds.

Pharmaceuticals

SUNPHARMACEUTICALSINDUSTRIES30 Apr 2024

₹

-19.50 (-1.28%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
24-Sep-2010	S	Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 24, 2010, has approved the proposal to sub-divide the nominal value of the equity shares of the Company from the nominal (face) value of Rs. 5 each to the nominal (face) value of Re. 1 each, subject to the approval of the Members of the Company. Sun Pharmaceutical Industries Ltd has informed BSE that the members of the Company, by way of Postal Ballot , have passed the following resolutions, with requisite majority: 1. Ordinaiy Resolution for Sub-division of Equity shares of the Company from face value Rs. 5/- each to face value Re. 1 each and consequent alteration of the Memorandum of Association. 2. Special Resolution for Alteration of the Articles of Association consequent to the sub-division of the shares of the Company from face value Rs. 5/- each to face value Re. 1/- each. (As Per BSE Announcement Website dated on 13.11.2010) Sun Pharmaceutical Industries Ltd has informed BSE that the Company has fixed November 26, 2010 as the Record Date for the purpose of ascertaining the names of the shareholders who would be entitled to receive 5 (five) equity shares of the nominal face value of Re. 1 each for every 1 (one) equity of Rs. 5 each held by them. (As Per BSE Announcement Website dated on 15.11.2010) SUB. :- Sub Division of equity shares of Sun Pharmaceutical Industries Limited (Scrip Code 524715) Trading Members of the Exchange are hereby informed that, Sun Pharmaceutical Industries Limited has fixed the Record Date for the purpose of sub division of equity shares of the company. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Sun Pharmaceutical Industries Limited (524715 & 624715) RECORD DATE 26.11.2010 PURPOSE Sub Division of existing equity shares from every ONE equity share of Rs.5/- each into FIVE equity shares of Re.1/- each. SUB-DIVIDED PAID-UP VALUE Re.1/- SUB-DIVIDED PAID-UP VALUEE W.E.F. 25/11/2010 DR-169/2010- 2011 Note :- i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Re. 1/- paid up w.e.f. 25/11/2010. ii. ISIN No. INE 044 A01028 of Rs.5/- paid up will not be valid for transactions done on the Exchange on or after 25/11/2010. iii. The new ISIN Number for Re.1- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 16.11.2010)	26-Nov-2010
28-Oct-2002	S	The Board of Directors of the company at its meeting held on 28/10/2002 has approved the following :- The Split / sub division of the company's equity shares of Rs.10/- each into 2 equity shares of Rs.5/- each subject to the approval of Equity shareholders at the ensuing EGM of the company. Sub-division of existing equity share from every one existing equity share of Rs. 10/- each into two equity shares of Rs. 5/- each. REDUCED PAID-UP VALE : Rs. 5/- REDUCED PAID-UP VALUE W.E.F. : 13.01.2003 (As Per BSE Notice Dated 06.01.2003)	21-Jan-2003
31-Jan-2024	D	Meeting of the Board of Directors of the Company ('Board') was held today i.e. January 31, 2024 which commenced at 10:20 a.m. and ended at 1:55 p.m., IST. The Board has, inter-alia, approved the following: Declaration of Interim Dividend for the financial year 2023-24 An interim dividend of Rs. 8.5/- (Rupees Eight and fifty paisa only) per equity share of Re. l/- (Rupee one only) each of the Company for the financial year 2023-24 is declared. As intimated on January 15, 2024, the Record Date for entitlement of interim dividend for the financial year 2023-24 is February 09, 2024. The interim dividend shall be paid on or before February 23, 2024.	09-Feb-2024
26-May-2023	D	With reference to the intimation of Board meeting submitted on May 11, 2023, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. May 26, 2023 which commenced at 10:40 a.m. and ended at 02:35 p.m., wherein the Board has, inter-alia, Recommended Final Dividend for financial year 2022-23 Final dividend of Rs. 4.00/- (Rupees Four only) per equity share of Re. l/- (Rupee One only) each of the Company is recommended subject to approval of the shareholders at the ensuing 31st Annual General Meeting and which shall be paid within the timelines as required under the Companies Act, 2013.	28-Jul-2023
31-Jan-2023	D	The Board has, inter-alia, Considered and approved declaration of Interim Dividend for the financial year 2022-23 An interim dividend of Rs. 7.50/- (Rupees seven and paise fifty only) per equity share of Re. l/- (Rupee one only) each of the Company for the financial year 2022-23. Further, as already intimated on January 16, 2023, the Record Date for entitlement of interim dividend for the financial year 2022-23 is February 08, 2023. The interim dividend shall be paid on or before February 20, 2023.	08-Feb-2023
30-May-2022	D	Attached Final dividend of Rs. 3.00 /- (Rupees Three only) per equity share of face value of Re.1/- each of the Company is recommended subject to the approval of the shareholders at the ensuing Annual General Meeting and which shall be paid within the timelines as required under the Companies Act, 2013.	19-Aug-2022
31-Jan-2022	D	Declared interim dividend of Rs. 7/- (Rupees Seven Only) per equity share of Re. l/- each of the Company for the financial year ending on March 31, 2022. Refer letter attached	09-Feb-2022
27-May-2021	D	Recommended payment of final dividend of Rs. 2/- (Rupees Two Only) per equity share of Re. l/-each of the Company for the year ended March 31, 2021, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The dividend is expected to be paid on or before about September 17, 2021.	23-Aug-2021
29-Jan-2021	D	The Board at its meeting held today, declared an interim dividend of Rs. 5.50/- (Rupees Five and paise fifty only) per equity share of Re. 1/- each of the Company for the financial year ending on March 31, 2021.	09-Feb-2021
27-May-2020	D	As per file attached	19-Aug-2020
06-Feb-2020	D	As per letter attached Sun Pharmaceutical Industries Ltd has informed BSE that the Company has fixed February 18, 2020 as the Record Date for the purpose of Payment of Interim Dividend. The payment of the interim dividend would be made to the eligible shareholders on or before February 24, 2020. (As Per BSE Announcement Dated on 07/02/2020)	17-Feb-2020
28-May-2019	D	Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 28, 2019, inter alia, has recommended payment of dividend of Rs. 2.75/- (Rupees Two and parse seventy five Only) per equity share of Re. 1/- each of the Company for the year ended March 31, 2019, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The dividend is expected to be paid on or about last week of August, 2019 or first week of September, 2019.	20-Aug-2019
25-May-2018	D	Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2018, inter alia, has recommended payment of dividend of Rs. 2/- (Rupees Two Only) per equity share of Re. 1/- each of the Company for the year ended March 31, 2018, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The dividend is expected to be paid on or about last week of September, 2018.	17-Sep-2018
26-May-2017	D	The Board of Directors of the Company at its meeting held today The Board of Directors of the Company at their meeting held today recommended payment of dividend of Rs. 3.5/- (Rupees Three and Fifty Paise Only) per equity share of Re.1/- each of the Company for the year ended March 31, 2017, subject to the approval of the members at the ensuing Annual General Meeting of the Company.	18-Sep-2017
30-May-2016	D	Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2016, inter alia, has transacted the following: 1. Recommended payment of dividend of Re. 1/- (Rupee One Only) per equity share of Re. 1/- each of the Company for the year ended March 31, 2016, subject to the approval of the members at the ensuing Annual General Meeting of the Company. The dividend will be paid on or about last week of September, 2016.	08-Sep-2016
11-Aug-2015	D	Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 11, 2015, inter alia, has recommended payment of dividend of Rs. 3 (Rupees Three Only) per equity share of Re. 1/- each of the Company for the year ended March 31, 2015, subject to the approval of the members at the ensuing Annual General Meeting of the Company to be held in around end of October 2015.	21-Oct-2015
13-Aug-2014	D	Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at their meeting held August 12, 2014 recorded approval of Scheme of Arrangement & Reconstruction between Sun Pharmaceutical Industries Ltd., and Sun Pharma Global FZE in the nature of demerger and transfer of the Specified Undertaking of Sun Pharma Global FZE to the Company with effect from the appointed date of May 01, 2013 as per the order of the Hon'ble High Court of Gujarat, at Ahmedabad at its hearing held on July 10, 2014 and accordingly after taking into effect of the above Scheme, approved the revised annual accounts for the year ended March 31, 2014. The Board of Directors of the Company also recommended payment of dividend of Rs. 1.50 (Rupees One and Fifty paise) per equity share of Re.1/- each of the Company for the year ended March 31, 2014, subject to the approval of the members at the ensuing Annual General Meeting of the Company.	11-Sep-2014
28-May-2013	D	Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2013, inter alia, has recommended payment of dividend of Rs. 5 (Rupees Five) per equity share of Re. 1/- each of the Company (pre bonus as recommended as below) for the year ended March 31, 2013 subject to the approval of the members at the ensuing Annual General Meeting of the Company. Sun Pharmaceutical Industries Ltd has informed BSE that post-Bonus dividend i.e. dividend now payable to the equity shareholders for the accounting year ended March 31, 2013 will be @ Rs. 2.50/- per outstanding equity share of Re. 1 each. (As per BSE Announcement Dated on 07.08.2013)	19-Sep-2013
29-May-2012	D	Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on may 29, 2012, inter alia, has recommended payment of dividend of Rs.4.25 (Rupees Four and paise Twenty Five) per equity share of Re.1/- each of the Company for the year ended March 31, 2012 subject to the approval of the members at the ensuing Annual General Meeting of the Company. The dividend, if declared by the shareholders will be paid on or after about September 20, 2012. Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 10, 2012, inter alia, have transacted the following : The Board of Directors further declared the interim dividend of Rs. 4.25 per Share of Re. 1 each on Equity Shares of the Company for the year ended March 31, 2012 in lieu of the earlier proposed dividend of Rs. 4.25 per Share of Re. 1 each on Equity Shares of the Company for the year ended March 31, 2012 in view of the likely delay for the redrawing and audit of the revised accounts for the year ended March 31, 2012 and adoption of accounts by the members so as to give effect to the proposed rationalisation of the business of the Company with effect from March 31, 2012. (AsPer BSE ANnouncement Website Dated on 10/08/2012)	14-Aug-2012
28-May-2011	D	Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2011, inter alia, has recommended payment of dividend of Rs. 3.50 (Rupees Three and paise fifty) per equity share of Re. 1/- each of the Company for the year ended March 31, 2011 subject to the approval of the members at the ensuing Annual General Meeting of the Company. The dividend, if declared by the shareholders will be paid on or after about September 20, 2011.	02-Sep-2011
24-May-2010	D	Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2010, inter alia, has recommended payment of dividend of Rs. 13.75 per equity share of Rs 5/- each of the Company for the year ended March 31, 2010 subject approval of the members.	09-Sep-2010
30-May-2009	D	Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2009, inter alia, has recommended payment of dividend of Rs 13.75 per equity share of Rs 5/- each of the Company for the year ended March 31, 2009 subject to the approval of the members at the ensuing Annual General Meeting of the Company.	21-Aug-2009
30-May-2008	D	Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2008, inter alia, has recommended payment of dividend @ 210% on the equity shares of the Company for the year ended March 31, 2008 subject to the approval of the members at the ensuing Annual General Meeting of the Company.	25-Aug-2008
12-Mar-2007	D	Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 10, 2007, has declared an interim dividend @ 6% p.a. on the outstanding 6% Cumulative Redeemable Preference Shares of Re 1/- each and @ 135% on equity shares of Rs 5/- each i.e. Rs 6.75 per equity share of Rs 5/- each of the Company for the year ended March 31, 2007. Sun Pharmaceutical Industries Ltd has informed BSE that: The Board of Directors had recommended that the interim dividend at the rate of 135% (Rs 6.75 per share) on the equity share capital and at the rate of 6% (Rs 0.06 per share) on the outstanding redeemable preference shares declared at its meeting held on March 10, 2007 and paid, be treated as final dividend for the financial year 2006-07. (As Per BSE Announcement Website Dated on 18/05/2007)	15-Mar-2007
31-Oct-2005	D	75% Dividend	19-Sep-2005
19-Jul-2013	B	SUB. :- Bonus issue of Sun Pharmaceutical Industries Ltd. (Scrip Code: 524715) Trading Members of the Exchange are hereby informed that Sun Pharmaceutical Industries Ltd. has fixed the Record Date for the purpose of Bonus Issue. The transactions in the equity shares of the Company should be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Sun Pharmaceutical Industries Ltd. (424715, 524715, 624715) RECORD DATE 30.07.2013 PURPOSE Issue of 1 (ONE) Bonus equity share of Re. 1/- each for every 1 (ONE) equity share of Re. 1/- each held. Ex-Bonus basis from Date & Sett. No. 29/07/2013 DR-086/2013-2014 Trading Members of the Exchange are requested to take note of it.	30-Jul-2013	1:1
14-May-2004	B	Members of the Exchange are hereby informed that, Sun Pharmaceuticals Ltd.has fixed the Record Date for the purpose of Bonus Issue. The transactions in the equity shares of the company should be done on an ex-bonus basis with effect from the undermentioned date. ONE Bonus share for every ONE existing Equity Share held in the company.	29-May-2004	1:1
05-Sep-2002	B	Four bonus 6% Cumulative Redeemable Preference shares of Re.1/- each for every one existing equity share held.	10-Oct-2002	4:1
08-Apr-2024	BC	Intimation of Notice of Postal Ballot / E-voting seeking approval of material related party transaction. POM 14/05/2024 (As Per BSE Bulletin Dated on 08.04.2024)	10-May-2024
31-Jan-2024	BC	Meeting of the Board of Directors of the Company ('Board') was held today i.e. January 31, 2024 which commenced at 10:20 a.m. and ended at 1:55 p.m., IST. The Board has, inter-alia, approved the foll	31-Mar-2024
29-Mar-2024	BC	Intimation regarding retirement of director upon completion of term.	31-Mar-2024
19-Feb-2024	BC	Trading Members of the Exchange are hereby informed that the under mentioned new securities of SUN PHARMACEUTICAL INDUSTRIES LTD. (Scrip Code: 524715) are listed and permitted to trade in with effect	20-Feb-2024
19-Feb-2024	BC	Trading Members of the Exchange are hereby informed that the under mentioned new securities of SUN PHARMACEUTICAL INDUSTRIES LTD (Scrip Code: 524715) are listed and permitted to trade in with effect	20-Feb-2024

Announcement Date31-Jan-2024

Ex Dividend Date09-Feb-2024

Dividend(%)850

Announcement Date26-May-2023

Ex Dividend Date28-Jul-2023

Dividend(%)400

Announcement Date31-Jan-2023

Ex Dividend Date08-Feb-2023

Dividend(%)750

Announcement Date30-May-2022

Ex Dividend Date19-Aug-2022

Dividend(%)300

Announcement Date31-Jan-2022

Ex Dividend Date09-Feb-2022

Dividend(%)700

Announcement Date27-May-2021

Ex Dividend Date23-Aug-2021

Dividend(%)200

Announcement Date29-Jan-2021

Ex Dividend Date09-Feb-2021

Dividend(%)550

Announcement Date27-May-2020

Ex Dividend Date19-Aug-2020

Dividend(%)100

Announcement Date06-Feb-2020

Ex Dividend Date17-Feb-2020

Dividend(%)300

Announcement Date28-May-2019

Ex Dividend Date20-Aug-2019

Dividend(%)275

Announcement Date25-May-2018

Ex Dividend Date17-Sep-2018

Dividend(%)200

Announcement Date26-May-2017

Ex Dividend Date18-Sep-2017

Dividend(%)350

Announcement Date30-May-2016

Ex Dividend Date08-Sep-2016

Dividend(%)100

Announcement Date11-Aug-2015

Ex Dividend Date21-Oct-2015

Dividend(%)300

Announcement Date13-Aug-2014

Ex Dividend Date11-Sep-2014

Dividend(%)150

Announcement Date28-May-2013

Ex Dividend Date19-Sep-2013

Dividend(%)250

Announcement Date29-May-2012

Ex Dividend Date14-Aug-2012

Dividend(%)425

Announcement Date28-May-2011

Ex Dividend Date02-Sep-2011

Dividend(%)350

Announcement Date24-May-2010

Ex Dividend Date09-Sep-2010

Dividend(%)275

Announcement Date30-May-2009

Ex Dividend Date21-Aug-2009

Dividend(%)275

Announcement Date30-May-2008

Ex Dividend Date25-Aug-2008

Dividend(%)210

Announcement Date12-Mar-2007

Ex Dividend Date15-Mar-2007

Dividend(%)135

Announcement Date31-Oct-2005

Ex Dividend Date19-Sep-2005

Dividend(%)75

No Rights has been declared by SUNPHARMACEUTICALSINDUSTRIES

Book Closure

Record Date	Split Date	Purpose
10-May-2024	01 Jan'1900	Intimation of Notice of Postal Ballot / E-voting seeking approval of material related party transaction. POM 14/05/2024 (As Per BSE Bulletin Dated on 08.04.2024)
31-Mar-2024	-	Meeting of the Board of Directors of the Company ('Board') was held today i.e. January 31, 2024 which commenced at 10:20 a.m. and ended at 1:55 p.m., IST. The Board has, inter-alia, approved the foll
31-Mar-2024	-	Intimation regarding retirement of director upon completion of term.
20-Feb-2024	-	Trading Members of the Exchange are hereby informed that the under mentioned new securities of SUN PHARMACEUTICAL INDUSTRIES LTD. (Scrip Code: 524715) are listed and permitted to trade in with effect
20-Feb-2024	-	Trading Members of the Exchange are hereby informed that the under mentioned new securities of SUN PHARMACEUTICAL INDUSTRIES LTD (Scrip Code: 524715) are listed and permitted to trade in with effect

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Sun Pharmaceuticals Industries Ltd ₹1,502.10(-19.50/-1.28%)	1,502.10	-19.50	360,404.11	54.37	87.50	14.99
Lupin Ltd ₹1,645.90(+8.45/0.52%)	1,645.90	+8.45	75,011.91	132.21	36.39	3.89
Ipca Laboratories Ltd ₹1,339.50(+5.50/0.41%)	1,339.50	+5.50	33,983.68	89.10	61.69	5.47
J B Chemicals & Pharmaceuticals Ltd ₹1,905.25(-1.40/-0.07%)	1,905.25	-1.40	29,568.49	83.20	58.37	11.01
Sanofi India Ltd ₹8,325.55(+48.05/0.58%)	8,325.55	+48.05	19,173.74	53.41	32.46	18.88
IOL Chemicals & Pharmaceuticals Ltd ₹393.70(-2.80/-0.71%)	393.70	-2.80	2,311.24	-3.87	13.46	1.46

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	4903.66	5019.54	4383.34	5800.85	4549.90	5181.72
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	4903.66	5019.54	4383.34	5800.85	4549.90	5181.72
Other Operating Income	170.09	76.67	82.73	147.37	95.85	103.57
Other Income	76.80	106.54	163.54	120.30	68.03	41.71
Total Income	5150.55	5202.75	4629.61	6068.52	4713.78	5327.00
Total Expenditure	3784.56	3709.89	3666.52	6525.36	3646.37	3622.12
PBIDT	1365.99	1492.86	963.09	-456.84	1067.41	1704.88
Interest	214.92	193.63	157.94	161.45	130.89	92.77
PBDT	1151.07	1299.23	805.15	-618.29	936.52	1612.11
Depreciation	399.60	392.71	415.27	411.98	430.44	383.95
Tax	30.16	17.89	9.24	-9.45	19.35	15.15
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	721.31	888.63	380.64	-1020.82	486.73	1213.01
Extra-ordinary Items	-67.01	0.00	-145.67	-2937.79	0.00	0.00
Adjusted Profit After Extra-ordinary item	788.32	888.63	526.31	1916.97	486.73	1213.01

EPS (Unit Curr.)	3.00	3.70	1.60	-4.30	2.00	5.10
EPS (Adj) (Unit Curr.)	3.00	3.70	1.60	-4.30	2.00	5.10
Calculated EPS (Unit Curr.)	3.01	3.70	1.59	-4.25	2.03	5.06
Calculated EPS (Adj) (Unit Curr.)	3.01	3.70	1.59	-4.25	2.03	5.06
Calculated EPS (Ann.) (Unit Curr.)	12.03	14.81	6.35	-17.02	8.11	20.22
Calculated EPS (Adj) (Ann.) (Unit Curr.)	12.03	14.81	6.35	-17.02	8.11	20.22
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	850.00	0.00	0.00	0.00	750.00	0.00
Equity	239.93	239.93	239.93	239.93	239.93	239.93
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00	1.00	1.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	27.86	29.74	21.97	-7.88	23.46	32.90
PBDTM(%)	23.47	25.88	18.37	-10.66	20.58	31.11
PATM(%)	14.71	17.70	8.68	-17.60	10.70	23.41

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	12156.86	12003.11	11785.15	10725.57	11100.14	10809.19
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	12156.86	12003.11	11785.15	10725.57	11100.14	10809.19
Other Operating Income	223.84	189.30	155.69	205.10	140.83	143.09
Other Income	250.20	293.61	204.44	373.28	173.88	85.22
Total Income	12630.90	12486.02	12145.28	11303.95	11414.85	11037.50
Total Expenditure	8973.68	9013.03	8931.94	8299.99	8237.25	7995.73
PBIDT	3657.22	3472.99	3213.34	3003.96	3177.60	3041.77
Interest	34.73	49.29	80.88	92.74	46.18	19.39
PBDT	3622.49	3423.70	3132.46	2911.22	3131.42	3022.38
Depreciation	622.14	632.82	651.32	671.53	659.95	609.95
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	432.32	390.10	468.10	222.91	283.43	152.26
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	2568.03	2400.78	2013.04	2016.78	2188.04	2260.17
Minority Interest After NP	36.79	9.59	-16.89	-1.57	14.74	-6.32
Net Profit after Minority Interest	2523.75	2375.51	2022.54	1984.47	2166.01	2262.22

Extra-ordinary Items	-59.75	0.00	-261.96	-154.39	0.00	0.00
Adjusted Profit After Extra-ordinary item	2583.50	2375.51	2284.50	2138.86	2166.01	2262.22

EPS (Unit Curr.)	10.50	9.90	8.40	8.30	9.00	9.40
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	850.00	0.00	0.00	0.00	750.00	0.00
Equity	239.93	239.93	239.93	239.93	239.93	239.93

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	30.08	28.93	27.27	28.01	28.63	28.14
PBDTM(%)	29.80	28.52	26.58	27.14	28.21	27.96
PATM(%)	21.12	20.00	17.08	18.80	19.71	20.91

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	239.93	239.93	239.93	239.93	239.93	239.93
Reserves Total	23508.43	24348.02	26698.54	24156.29	22603.68	22082.68
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	23748.36	24587.95	26938.47	24396.22	22843.61	22322.61
Secured Loans	0.00	0.00	5.41	6.18	9.73	10.82
Unsecured Loans	7790.82	5074.04	7352.71	6399.70	6426.91	6873.19
Total Debt	7790.82	5074.04	7358.12	6405.88	6436.64	6884.01
Total Liabilities	31539.18	29661.99	34296.59	30802.10	29280.25	29206.62
APPLICATION OF FUNDS :
Gross Block	17744.68	17194.98	15812.29	8244.71	7461.34	6572.66
Less : Accumulated Depreciation	9033.01	7482.20	6143.50	3015.97	2482.92	1928.09
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	8711.67	9712.78	9668.79	5228.74	4978.42	4644.57
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	852.91	828.64	1090.38	596.61	642.54	987.84
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	12616.40	15548.87	15537.20	17361.72	17904.11	18355.26
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	3989.19	3403.74	3423.42	2633.67	2792.62	2135.64
Sundry Debtors	7125.02	4245.16	6585.24	6168.13	5031.47	5271.44
Cash and Bank	421.28	534.96	360.98	654.78	340.77	155.27
Loans and Advances	4708.00	1326.85	2329.44	2089.47	2756.96	1968.10
Total Current Assets	16243.49	9510.71	12699.08	11546.05	10921.82	9530.45
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	7533.98	7524.56	6891.41	4956.61	5713.96	4586.35
Provisions	809.50	2562.55	1204.66	1097.94	2543.73	2652.75
Total Current Liabilities	8343.48	10087.11	8096.07	6054.55	8257.69	7239.10
Net Current Assets	7900.01	-576.40	4603.01	5491.50	2664.13	2291.35
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	1982.84	1389.47	1969.40	1704.22	1427.47	751.70
Deferred Tax Liability	950.45	1065.43	631.95	564.51	675.77	0.00
Net Deferred Tax	1032.39	324.04	1337.45	1139.71	751.70	751.70
Total Assets	31113.38	25837.93	32236.83	29818.28	26940.90	27030.72
Contingent Liabilities	1087.40	1031.72	3083.04	3439.72	3639.13	5708.85

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	239.93	239.93	239.93	239.93	239.93	239.93
Reserves Total	55755.45	47771.29	46222.85	45024.52	41169.13	38074.18
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	55995.38	48011.22	46462.78	45264.45	41409.06	38314.11
Minority Interest	3320.09	3054.89	3017.05	3860.24	3313.54	3884.16
Secured Loans	0.00	0.00	7.83	257.49	109.47	114.35
Unsecured Loans	6885.87	1290.30	3860.75	8057.39	10404.89	10270.92
Total Debt	6885.87	1290.30	3868.58	8314.88	10514.36	10385.27
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	929.52	1019.64	1098.63	1334.28	1004.70	462.71
Total Liabilities	67130.86	53376.05	54447.04	58773.85	56241.66	53046.25
APPLICATION OF FUNDS :
Gross Block	43454.63	38707.36	35578.99	35115.97	31687.04	26948.81
Less: Accumulated Depreciation	19034.51	16042.20	14026.01	12269.06	9850.50	8096.16
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	24420.12	22665.16	21552.98	22846.91	21836.54	18852.65
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	4973.16	1286.80	1566.83	1220.34	1411.15	2465.16
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	14830.09	12848.59	9612.45	10143.11	7902.53	7142.87
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	10513.05	8925.13	8997.02	7874.99	7885.98	6880.69
Sundry Debtors	11438.51	10484.59	9061.40	9421.24	8884.20	7815.28
Cash and Bank	5770.29	5033.35	6445.51	6487.55	7275.60	9929.38
Loans and Advances	2767.48	2787.59	2808.09	2973.02	3072.69	2919.93
Total Current Assets	30489.33	27230.66	27312.02	26756.80	27118.47	27545.28
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	7917.95	7076.42	8413.45	5382.08	5288.60	6008.65
Provisions	5663.09	9323.44	4761.73	4038.39	3059.27	5242.49
Total Current Liabilities	13581.04	16399.86	13175.18	9420.47	8347.87	11251.14
Net Current Assets	16908.29	10830.80	14136.84	17336.33	18770.60	16294.14
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	5409.36	4431.17	4712.19	4141.50	3441.01	3095.50
Deferred Tax Liability	2276.81	1613.45	1200.26	1024.35	990.42	907.13
Net Deferred Tax	3132.55	2817.72	3511.93	3117.15	2450.59	2188.37
Other Assets	2866.65	2926.98	4066.01	4110.01	3870.25	6103.06
Total Assets
Contingent Liabilities	4361.77	3773.19	4714.13	5075.52	5290.40	7430.51

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	419.53	351.06	314.83	302.76	97.80
Net Cash from Operating Activities	507.08	7636.36	-416.51	1305.85	1242.18
Net Cash Used In Investing Activities	-685.64	-2697.04	1452.47	1483.04	431.37
Net Cash Used In Financing Activities	169.31	-4870.85	-999.73	-2871.15	-1468.59
Net Inc./Dec In Cash And Cash Equivalents	-9.25	68.47	36.23	-82.26	204.96
Cash And Cash Equivalents At End Of The Year	410.28	419.53	351.06	220.50	302.76

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

54.48%

FII Shareholding

17.72%

DII Shareholding

18.83%

Public Shareholding

8.97%

**Promoter pledged shareholding 54.48%

About Sun Pharmaceuticals Industries Ltd

Sun Pharmaceuticals Industries Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 360452.09 crores. It has reported a sales of Rs. 4903.66 crores and a net profit of Rs. 721.31 crores for the quarter ended December 2018. The company management includes , Dilip S Shanghvi,Sudhir V Valia,Sailesh T Desai,Gautam Doshi,Pawan Goenka,Rama Bijapurkar,Anoop Deshpande,Sanjay K Asher,Rolf Hoffmann,Aalok Shanghvi (Sun Pharmaceuticals Industries Ltd) among others.

Chairman

Registered office

Sun Pharma Advanced Res.Centre,Tandalja,Vadodara,Gujarat,390020

FAX :91-265-2354897

Background

Incorporation Year1993

Face Value₹1

Market Lot1

How to buy Sun Pharma.Inds. shares on nse?

To buy Sun Pharma.Inds. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Sun Pharma.Inds. share price today?

The Sun Pharma.Inds. shares price on nse is Rs.1502.1 today.

What is the market cap of Sun Pharma.Inds. shares on NSE ?

The company has a market capitalization of Rs.360404.11Cr

What is the PE & PB ratio of Sun Pharma.Inds. shares ?

PE is 87.5 and PB is 14.99

What is the 52 Week High and Low of Sun Pharma.Inds. shares?

Sun Pharma.Inds. stock price high: Rs.1638.85 Sun Pharma.Inds. stock price low: Rs.922.45

How much dividend does Sun Pharma give?

The dividend that Sun Pharma pays depends on its profits and retained earnings. The last dividend that the company declared was on 31st January 2023. It declared an interim dividend of 7.50 per share. Before that, on 30th May 2022, the company had declared a final dividend of 3 per share.

How can I sell Sun Pharma Industries stocks?

You can sell Sun Pharma Industries’ stocks online through your stockbroker. Just choose the number of shares you want to sell and place an order. You can sell during market hours and on trading days.

What is the ROI of Sun Pharma Industries stocks?

The Return on Investment (ROI) depends on the amount you invest and the interest earned thereon. It includes the dividend income you earn and the capital gain incurred when you sell the stock.

How has the Sun Pharma Industries stock price performed last year?

In the last year, the 52-week high was recorded at 1071.90, and the 52-week low was 789.75. The one-year return was 8.14% as of 9th May 2023.

What is the trending volume of Sun Pharma Industries stocks?

The traded volume of Sun Pharma was 61,540 when the markets closed on 9th May 2023. The volume fluctuates daily based on share price movements, market sentiments, and the company’s financial performance.

How often are dividends paid on Sun Pharma Industries stocks?

The dividend payment depends on the company’s financial performance. However, the company has consistently paid annual dividends in the last few years in May. Moreover, an interim dividend was also paid in January or February over the last four years.